BIOTRAK SERVICES
Portfolio Decision Analysis
and Market Analytics

Our consulting solutions help optimize deal terms and R&D investments for maximum Expected Net Present Value (ENPV). We combine techniques such as Decision Tree Analysis (DTA), Monte Carlo simulation, Real Options, quantitative risk analysis, and Optimizer along with primary and secondary data collection to deliver exceptional, reality-based results.

Technology and product portfolios require regular review to assess and analyze survivability and viability. The portfolio should contain assets that can be applied throughout the projected lifespan of the company. What effect will the various healthcare market forces have on the portfolio? Where are the gaps? Can they be filled? How can we strengthen our portfolio? At what cost? BioTrak leads clients though the process of screening and analyzing current and planned programs and assist them in determining strategic fit based on the most appropriate metrics (ie profit margin, revenue, market need, partnering potential etc)

Forecasts
Our market analytic techniques provide reliable, realistic predictive forecasts. BioTrak Research has developed unique models, such as the Covariance Outcome Prediction Model (COPM), to improve accuracy and confidence in sales forecasts and market sizing. We apply Monte Carlo simulation and other statistical methods for sensitivity analysis, and utilize advanced software programs for econometric modeling and trend projection.

Market Analytics
Our primary research methods can test clinical utility, measure awareness, and support sensitivity analysis of price or featured attributes for new and existing products and technologies. Our quantitative and qualitative research methods are leading the industry in its application to product and commercial planning. Such methods are applied in Awareness, Trial, and Usage (ATU) studies, discrete choice and conjoint analysis, and various other multivariate analysis techniques.